The increasingly popular class of drugs known as GLP-1 receptor activators are changing diabetes management , but the route of administration is shifting to a key factor . Initially , these powerful medications were offered solely in capsule form. However, alternative transdermal systems are now appearing , prompting many patients to wonder which c